Package 51662-1398-1

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1398-1
Digits Only 5166213981
Product NDC 51662-1398
Product ID 51662-1398_11c32120-cce5-3b72-e063-6394a90ac42a
Description

4 mL in 1 VIAL (51662-1398-1)

Marketing

Marketing Status
Marketed Since 2019-10-17
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "11c32120-cce5-3b72-e063-6394a90ac42a", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665061"], "spl_set_id": ["951c7fd7-10ef-2b07-e053-2995a90aaffd"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "4 mL in 1 VIAL (51662-1398-1)", "package_ndc": "51662-1398-1", "marketing_start_date": "20191017"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1398-3)  / 1 mL in 1 POUCH (51662-1398-2)", "package_ndc": "51662-1398-3", "marketing_start_date": "20210112"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51662-1398_11c32120-cce5-3b72-e063-6394a90ac42a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1398", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA070737", "marketing_category": "ANDA", "marketing_start_date": "20191017", "listing_expiration_date": "20261231"}